Recommendation ID
NICE recommended further research to explore the impact of having experiences of patients having continuous infusion 5-FU and take into account the impact on quality of life. The potential consequences of introducing pharmacokinetic dose adjustment should also be explored.
Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment
Date issued
December 2014

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 07/01/2015